These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6394671)

  • 1. [Symposium on treatment of cancer. 1. Chemotherapy of acute leukemia in adults].
    Yamada K
    Nihon Naika Gakkai Zasshi; 1984 Nov; 73(11):1585-9. PubMed ID: 6394671
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotherapy of acute leukemia in adults.
    Yamada K
    Jpn J Med; 1985 Feb; 24(1):73-5. PubMed ID: 3858569
    [No Abstract]   [Full Text] [Related]  

  • 3. [Development of new antileukemic agents].
    Yamada K; Ohno R
    Nihon Rinsho; 1981 Aug; 39(8):2815-20. PubMed ID: 7038206
    [No Abstract]   [Full Text] [Related]  

  • 4. Overview of progress in hematology in 1981 with special reference to leukocyte.
    Kimura K
    Nihon Ketsueki Gakkai Zasshi; 1982 Feb; 45(1):1-10. PubMed ID: 7051724
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy of acute leukemia: contribution of the new anthracyclinic drugs].
    Lambertenghi-Deliliers G; Colajori E; Annaloro C; Polli EE
    Recenti Prog Med; 1985; 76(7-8):392-7. PubMed ID: 3906794
    [No Abstract]   [Full Text] [Related]  

  • 6. Aclarubicin in the treatment of acute nonlymphocytic leukemia refractory to treatment with daunorubicin and cytarabine: a phase II trial.
    Pedersen-Bjergaard J; Brincker H; Ellegaard J; Drivsholm A; Freund L; Jensen KB; Jensen MK; Nissen NI
    Cancer Treat Rep; 1984 Oct; 68(10):1233-8. PubMed ID: 6597002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anthracycline antineoplastic drugs.
    Young RC; Ozols RF; Myers CE
    N Engl J Med; 1981 Jul; 305(3):139-53. PubMed ID: 7017406
    [No Abstract]   [Full Text] [Related]  

  • 8. A phase II study of aclacinomycin A in acute leukemia in adults.
    Yamada K; Nakamura T; Tsuruo T; Kitahara T; Maekawa T; Uzaka Y; Kurita S; Masaoka T; Takaku F; Hirota Y; Amaki I; Osamura S; Ito M; Nakano N; Oguro M; Inagaki J; Onozawa K
    Cancer Treat Rev; 1980 Dec; 7(4):177-82. PubMed ID: 6938305
    [No Abstract]   [Full Text] [Related]  

  • 9. [New agents in the treatment of leukemia and lymphoma].
    Yamada K
    Gan To Kagaku Ryoho; 1983 Apr; 10(4 Pt 2):1031-40. PubMed ID: 6347079
    [No Abstract]   [Full Text] [Related]  

  • 10. Action mechanism of antileukemic agents with special reference to nucleic acid metabolism of leukemic cells.
    Nakamura T
    Nihon Ketsueki Gakkai Zasshi; 1982 Dec; 45(7):1203-18. PubMed ID: 6762793
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase II trial of aclacinomycin in acute leukemia and lymphosarcoma.
    Mathé G; Gil MA; Delgado M; Bayssas M; Gouveia J; Ribaud P; Machover D; Misset JL; de Vassal F; Schwarzenberg L; Jasmin C; Hayat M
    Recent Results Cancer Res; 1980; 74():217-22. PubMed ID: 6893752
    [No Abstract]   [Full Text] [Related]  

  • 12. Aclacinomycin A.
    Oka S; Mathé G; Mitrou PS
    Cancer Treat Rev; 1984 Dec; 11(4):299-302. PubMed ID: 6598408
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical assessment of the structure-activity relationship of anthracyclines and related synthetic derivatives.
    Young CW; Raymond V
    Cancer Treat Rep; 1986 Jan; 70(1):51-63. PubMed ID: 2935251
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical studies of aclacinomycin A (ACM).
    Majima H; Ohta K
    Biomed Pharmacother; 1987; 41(5):233-7. PubMed ID: 3311189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of aclarubicin in patients with breast cancer previously untreated with adriamycin.
    Kerpel-Fronius S; Gyergyay F; Hindy I; Decker A; Sawinsky I; Mechl Z; Nekulova M; Kolariĉ K; Tomek R; Röthig J
    Eur J Haematol Suppl; 1987; 47():67-9. PubMed ID: 3471527
    [No Abstract]   [Full Text] [Related]  

  • 16. [Gastrointestinal symptoms of aclacinomycin A in patients with adult acute nonlymphocytic leukemia--comparison of BH-AC-DMP therapy and BH-AC-AMP therapy].
    Kawano F; Tajima H; Matsuoka Y; Asou N; Takatsuki K
    Rinsho Ketsueki; 1985 Apr; 26(4):494-8. PubMed ID: 3862889
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of juvenile chronic myelocytic leukemia with multidrug chemotherapy including aclacinomycin and N4-behenoyl-1-beta-D-arabinofuranosylcytosine.
    Ishii E; Matsuzaki A; Kato Y; Miyazaki S; Ueda K
    Nihon Ketsueki Gakkai Zasshi; 1986 Sep; 49(6):1297-9. PubMed ID: 3468729
    [No Abstract]   [Full Text] [Related]  

  • 18. Phase II study of aclarubicin in acute myeloblastic leukemia.
    Case DC; Ervin TJ; Boyd MA; Bove LG; Sonneborn HL; Paul SD
    Am J Clin Oncol; 1987 Dec; 10(6):523-6. PubMed ID: 3479891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Acute pancreatitis during the treatment of BH-AC AMP regimen for acute non-lymphocytic leukemia].
    Onozawa Y; Yahara Y; Imai Y; Kawaguchi K; Higashidani M; Yoshida M
    Rinsho Ketsueki; 1984 Nov; 25(11):1766-71. PubMed ID: 6543456
    [No Abstract]   [Full Text] [Related]  

  • 20. Aclarubicin in single agent and combined chemotherapy of acute myeloid leukaemias.
    Mitrou PS
    Eur J Haematol Suppl; 1987; 47():59-66. PubMed ID: 3471526
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.